bioAffinity Technologies, Inc. · Brief

Next report

9 days

Nov 13 · before openest.Q3 FY26

Expected move

No implied move.

—≥ implied

Q2 FY26—▼−3.72%—

quarterimplied−5%0+5%realized×

Q2 FY26—▼−3.72%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 13 report · est.

—

BIAF report session

No linked exposure.

Oct 98-KMaterial agreement: 8-K Item 1.01.Source

Oct 8haltTrading halt: 12:07 ET, resumed 12:17 ET.Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.